Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

I C U Medical Inc (ICUI)

I C U Medical Inc (ICUI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,093,410
  • Shares Outstanding, K 24,690
  • Annual Sales, $ 2,231 M
  • Annual Income, $ 730 K
  • EBIT $ 43 M
  • EBITDA $ 250 M
  • 60-Month Beta 0.79
  • Price/Sales 1.44
  • Price/Cash Flow 8.95
  • Price/Book 1.52

Options Overview Details

View History
  • Implied Volatility 41.98% (-0.40%)
  • Historical Volatility 39.50%
  • IV Percentile 23%
  • IV Rank 16.82%
  • IV High 76.89% on 04/08/25
  • IV Low 34.93% on 12/22/25
  • Expected Move (DTE 1) 3.40 (2.68%)
  • Put/Call Vol Ratio 4.00
  • Today's Volume 20
  • Volume Avg (30-Day) 46
  • Put/Call OI Ratio 2.32
  • Today's Open Interest 668
  • Open Int (30-Day) 429
  • Expected Range 123.23 to 130.03

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 1.35
  • Number of Estimates 3
  • High Estimate 1.46
  • Low Estimate 1.29
  • Prior Year 1.34
  • Growth Rate Est. (year over year) +0.75%

Price Performance

See More
Period Period Low Period High Performance
1-Month
123.53 +2.51%
on 03/17/26
159.89 -20.80%
on 02/20/26
-23.11 (-15.43%)
since 02/19/26
3-Month
123.53 +2.51%
on 03/17/26
160.29 -21.00%
on 01/22/26
-18.52 (-12.76%)
since 12/19/25
52-Week
107.00 +18.35%
on 08/11/25
160.29 -21.00%
on 01/22/26
-24.62 (-16.28%)
since 03/19/25

Most Recent Stories

More News
3 Profitable Stocks We Keep Off Our Radar

3 Profitable Stocks We Keep Off Our Radar

NWSA : 23.93 (-0.71%)
KMI : 33.44 (+2.55%)
ICUI : 126.63 (+1.07%)
3 Russell 2000 Stocks We Steer Clear Of

3 Russell 2000 Stocks We Steer Clear Of

ACT : 40.64 (+0.54%)
ICUI : 126.63 (+1.07%)
LNN : 115.30 (-1.14%)
2 Healthcare Stocks with Exciting Potential and 1 We Avoid

2 Healthcare Stocks with Exciting Potential and 1 We Avoid

MEDP : 460.92 (+1.35%)
ICUI : 126.63 (+1.07%)
ISRG : 479.93 (+0.46%)
Integra LifeSciences, GE HealthCare, Bausch + Lomb, ICU Medical, and Universal Health Services Shares Are Falling, What You Need To Know

Integra LifeSciences, GE HealthCare, Bausch + Lomb, ICU Medical, and Universal Health Services Shares Are Falling, What You Need To Know

UHS : 187.22 (-1.24%)
IART : 8.90 (unch)
GEHC : 70.38 (+0.19%)
BLCO : 16.17 (+0.94%)
ICUI : 126.63 (+1.07%)
ICU Medical to Participate in Upcoming Investor Conferences

SAN CLEMENTE, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced its participation...

ICUI : 126.63 (+1.07%)
ICU Medical’s (NASDAQ:ICUI) Q4 CY2025: Beats On Revenue

ICU Medical’s (NASDAQ:ICUI) Q4 CY2025: Beats On Revenue

ICUI : 126.63 (+1.07%)
ICU Medical: Q4 Earnings Snapshot

ICU Medical: Q4 Earnings Snapshot

ICUI : 126.63 (+1.07%)
ICU Medical Announces Fourth Quarter 2025 Results and Provides Fiscal Year 2026 Guidance

SAN CLEMENTE, Calif., Feb. 19, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results...

ICUI : 126.63 (+1.07%)
What To Expect From ICU Medical’s (ICUI) Q4 Earnings

What To Expect From ICU Medical’s (ICUI) Q4 Earnings

ICUI : 126.63 (+1.07%)
1 of Wall Street’s Favorite Stock on Our Buy List and 2 We Find Risky

1 of Wall Street’s Favorite Stock on Our Buy List and 2 We Find Risky

NOW : 113.27 (-0.39%)
BYRN : 9.16 (-4.28%)
ICUI : 126.63 (+1.07%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

ICU Medical, Inc. develops, manufactures and sells innovative medical devices used in vascular therapy, oncology and critical care applications. They are one of the world's leading pure-play infusion therapy companies, with global operations and a wide-ranging product portfolio that includes IV solutions,...

See More

Key Turning Points

3rd Resistance Point 134.87
2nd Resistance Point 132.74
1st Resistance Point 129.01
Last Price 126.63
1st Support Level 123.16
2nd Support Level 121.03
3rd Support Level 117.30

See More

52-Week High 160.29
Fibonacci 61.8% 139.93
Fibonacci 50% 133.64
Fibonacci 38.2% 127.36
Last Price 126.63
52-Week Low 107.00

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar